Package Leaflet: Information for the User
TRAVATAN 40 micrograms/ml eye drops, solution
travoprost
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
TRAVATAN contains travoprostwhich belongs to a group of medicines called prostaglandin analogues. It works by reducing the pressure in the eye. It can be used on its own or with other eye drops, for example beta blockers, which also reduce the pressure in the eye.
TRAVATAN is used to reduce high pressure in the eye in adults, adolescents, and children from 2 months of age. This pressure can lead to a condition called glaucoma.
Do not use TRAVATAN
Tell your doctor if you are in this situation.
Warnings and precautions
Children and adolescents
TRAVATAN can be used in children from 2 months of age to less than 18 years of age with the same dose as in adults. The use of TRAVATAN is not recommended in children under 2 months of age.
Other medicines and TRAVATAN
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Pregnancy, breast-feeding and fertility
Do not use TRAVATAN if you are pregnant. If you could be pregnant, tell your doctor. If you can become pregnant, use an effective method of birth control while using TRAVATAN.
Do not use TRAVATAN if you are breast-feeding. TRAVATAN may pass into breast milk.
Consult your doctor before using any medicine.
Driving and using machines
Immediately after applying TRAVATAN, you may notice that your vision becomes blurred. Do not drive or use machines until these effects have disappeared.
TRAVATAN contains hydrogenated castor oil and propylene glycol, which may cause skin reactions and irritation.
Follow exactly the instructions of your doctor or the doctor treating the child. If you are unsure, consult your doctor, the doctor treating the child, or pharmacist.
The recommended dose is
One drop in the affected eye(s) once a day - in the evening.
TRAVATAN should only be applied in both eyes if your doctor has told you to do so. Continue the treatment for the whole period of time prescribed by your doctor or the doctor treating the child.
TRAVATAN should only be used as eye drops.
If a drop falls outside the eye, try again.
If you or the child are using other eye medicines, such as eye drops or ointments, wait at least 5 minutes between applying TRAVATAN and the other eye medicines.
If you or the child get more TRAVATAN than needed
You can flush it out with warm water. Do not apply more drops until it is time for the next dose.
If you forget to use TRAVATAN
Continue with the next dose as planned. Do not apply a double doseto make up for a forgotten dose. Never apply more than one drop in the affected eye(s) in one day.
If you stop using TRAVATAN
Do not stop using TRAVATAN without consulting your doctor or the doctor treating the child, as the pressure in your eye or the child's eye will not be controlled, which could lead to loss of vision.
If you have any other questions about using this medicine, ask your doctor, the doctor treating the child, or pharmacist.
Continue
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You can carry on using the treatment as usual, unless the side effects are serious. If they are, tell your doctor or pharmacist. Do not stop using TRAVATAN without talking to your doctor.
The following side effects have been seen with TRAVATAN:
Very common: may affect more than 1 in 10 people
Eye effects:redness of the eye.
Common: may affect up to 1 in 10 people
Eye effects:changes in iris color (the colored part of the eye), eye pain, discomfort in the eye, dry eye, itching in the eye, irritation in the eye.
Uncommon: may affect up to 1 in 100 people
Eye effects:corneal changes, eye inflammation, iris inflammation, inflammation inside the eye, inflammation with or without damage to the surface of the eye, sensitivity to light, eye discharge, eyelid inflammation, eyelid redness, swelling around the eye, itching of the eyelid, blurred vision, increased tear production, conjunctivitis (inflammation or infection of the conjunctiva), abnormal turning out of the lower eyelid, darkened vision, crusts on the eyelid, eyelash growth.
Other effects:increased allergic symptoms, headache, irregular heartbeat, cough, stuffy nose, sore throat, darkening of the skin around the eyes, darkening of the skin, abnormal hair texture, excessive hair growth.
Rare: may affect up to 1 in 1,000 people
Eye effects:flashes of light, eyelid eczema, abnormally positioned eyelashes that grow towards the eye, eye swelling, reduced vision, halos around lights, decreased sensation in the eye, inflammation of the eyelid glands, pigmentation inside the eye, increased pupil size, thickening of the eyelashes, change in eyelash color, tired eyes.
Other effects:viral eye infection, dizziness, bad taste, irregular or decreased heartbeat, increased or decreased blood pressure, shortness of breath, asthma, nasal inflammation or allergy, nasal dryness, voice changes, gastrointestinal ulcer or discomfort, constipation, dry mouth, skin redness or itching, rash, hair color change, loss of eyelashes, joint pain, muscle pain, general weakness.
Frequency not known: cannot be estimated from the available data
Eye effects:inflammation of the back of the eye, sunken eyes.
Other effects:depression, anxiety, insomnia, feeling of false movement, ringing in the ears, chest pain, irregular heartbeat, increased heart rate, worsening of asthma, diarrhea, nosebleeds, abdominal pain, nausea, vomiting, itching, abnormal hair growth, painful or involuntary urination (painful or involuntary urination), increased prostate cancer marker.
In children and adolescents, the most common side effects seen with TRAVATAN are redness of the eye and eyelash growth. Both side effects were seen more frequently in children and adolescents compared to adults.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use TRAVATAN after the expiry date which is stated on the bottle and the carton after “EXP”. The expiry date is the last day of the month shown.
This medicine does not require any special storage conditions.
To avoid infections, you must discard the bottle 4 weeks after you first open it, and use a new bottle. Write the date you opened it on the space provided on the carton.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What TRAVATAN contains
The active substance is travoprost 40 micrograms/ml.
The other ingredients are: Polyquaternium-1, hydrogenated castor oil, and polyoxyethylene 40, propylene glycol, sodium chloride, boric acid, mannitol, and purified water. Small amounts of hydrochloric acid or sodium hydroxide are added to maintain normal levels of acidity (pH levels).
Appearance and packaging
TRAVATAN is a liquid (a clear, colorless solution) that comes in a carton containing a 4 ml plastic bottle with a screw cap. Each bottle contains 2.5 ml of travoprost eye drops, and each bottle is in a pouch.
Pack sizes: 1 or 3 bottles.
Not all pack sizes may be marketed.
Marketing authorisation holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Manufacturing NV
Rijksweg 14
2870 Puurs-Sint-Amands
Belgium
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Germany
Siegfried El Masnou, S.A.
Camil Fabra 58
El Masnou
08320 Barcelona
Spain
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
You can get more information about this medicine by contacting the local representative of the marketing authorisation holder:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | |
Ceská republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 88 04 52 111 |
Eesti SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Ελλáδα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: + 421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel: +358 (0)10 6133 200 |
Κúπρος Novartis Pharma Services Inc. Τηλ: +357 22 690 690 | Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvija SIA Novartis Baltics Tel: +371 67 887 070 |
Date of last revision of this leaflet
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu